Vimarsana
Biggest News Aggregation in the World

Wound Contacts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wound Contacts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wound Contacts Today - Breaking & Trending Today

MediWound to Report First Quarter 2024 Financial Results - Vimarsana News

MediWound to Report First Quarter 2024 Financial Results

Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time...

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns - Vimarsana News

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

If approved, NexoBrid will serve as an effective non-surgical treatment for both pediatric and adult burn patients in the U.S. NexoBrid is already approved for use for burn patients across all age groups in Europe and Japan YAVNE, Israel, Jan. 09, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Food and Drug Administration (FDA) has completed the

Source: yahoo.com
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army - Vimarsana News

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE, Israel, Dec. 28, 2023 -- MediWound Ltd. , a...

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® ... - Vimarsana News

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® ...

YAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Department

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer - Vimarsana News

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

YAVNE, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-gen...